Related Experiment Video
Updated: Jun 18, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous
Yoshitaka Inoue1,2,3, Hunmin Lee1, Tianfan Fu4
1Department of Computer Science and Engineering, University of Minnesota, 200 Union Street SE, Minneapolis, MN, 55455, USA.
This study introduces drGT, a novel graph deep learning model for accurate drug response prediction and biological interpretability. drGT achieves state-of-the-art performance, uncovering biologically plausible drug-gene interactions for enhanced drug discovery.
Area of Science:
- Computational Biology
- Pharmacogenomics
- Machine Learning
Background:
- Accurate drug response prediction is crucial for translational medicine.
- Biological plausibility of predictive features is essential for understanding drug mechanisms.
- Existing models often lack interpretability, hindering biological discovery.
Purpose of the Study:
- To develop drGT, a heterogeneous graph deep learning model for drug response prediction.
- To couple prediction accuracy with mechanism-oriented interpretability using attention coefficients (ACs).
- To assess the model's predictive generalization and biological plausibility across diverse datasets.
Main Methods:
- Utilized a heterogeneous graph deep learning approach integrating drugs, genes, and cell lines.
- Employed attention coefficients (ACs) for mechanism-oriented interpretability.
- Evaluated on GDSC, NCI60, and CTRP datasets using various cross-validation strategies (random, unseen-drug, unseen-cell, zero-shot).
- Assessed biological plausibility using text-mined PubMed gene-drug co-mentions and a structure-based drug-target interaction (DTI) predictor.
Main Results:
- drGT achieved top regression performance and competitive classification accuracy for drug sensitivity across benchmarks.
- Outperformed baselines in regression under random 5-fold cross-validation (up to R²=0.690).
- Demonstrated strong performance in leave-one-out tests for unseen cell lines (AUROC=0.706) and drugs (AUROC=0.844, R²=0.022).
- Achieved highest scores in zero-shot prediction (AUROC=0.786, R²=0.334).
- AC-derived drug-gene links showed high concordance with known DTIs (36.9%) and literature support (63.7%).
- Enrichment analyses of AC-prioritized genes revealed drug-perturbed biological processes.
Conclusions:
- drGT advances predictive generalization and mechanism-centered interpretability in drug response prediction.
- Offers state-of-the-art regression accuracy and generates literature-supported biological hypotheses.
- Demonstrates the utility of graph learning from heterogeneous data for biological discovery.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
